Probiotic strain selection can influence product formulation, labeling, marketing and, ultimately, consumers.

From stability testing to labeling, scientifically based best practices should be followed for dietary supplements containing probiotics.

Many states have adopted laws and regulations which directly contradict FDA’s guidance that CBD may not be used in ingestible products.

While CBD sales are far from completely stalling, factors such as inaccurate messaging, poor quality control and regulatory uncertainty are hindering market potential.

Consumers from all walks of life are seeking innovative and proven supplements that will help keep them mentally sharp.

Two incompatible trends are colliding in the U.S. wellness market, as consumers living a plant-based lifestyle try to reconcile the source of collagen is animals.

While it can be acceptable for a dietary supplement to claim to support a healthy immune system, the brand cannot overtly state or imply the product cures or prevents a disease such as COVID-19 or the flu.

Retailers have started to develop and implement verification programs to improve quality and accountability in dietary supplements.

ISAPP’s efforts to provide language to the probiotic/prebiotic space may aid brands bringing products to market.

Processing aids used during manufacturing can help improve product quality, enhance appearance and shelf life, aid with packing and transportation, and more.